Outcomes of primary ligation of patent ductus arteriosus compared with secondary ligation after pharmacologic failure in very-low-birth-weight infants
- PMID: 24370764
- PMCID: PMC4015055
- DOI: 10.1007/s00246-013-0854-6
Outcomes of primary ligation of patent ductus arteriosus compared with secondary ligation after pharmacologic failure in very-low-birth-weight infants
Abstract
This study aimed to determine whether primary surgical closure of patent ductus arteriosus (PDA) is a risk factor for morbidity and mortality compared with secondary surgical ligation. The study enrolled 178 very-low-birth-weight infants. The surgical group included 34 patients who did not respond to pharmacologic intervention and eventually required ligation of their PDA as well as 35 patients who underwent direct ligation because of contraindications to the use of oral ibuprofen. The overall outcomes for the primary and secondary ligation groups were compared. The outcome during hospitalization showed no statistically significant difference in terms of morbidity and mortality between the two groups. The group that had primary ligation for PDA experienced more complications associated with premature birth such as lower gestational age and birth weight. The two groups did not differ significantly in terms of overall outcomes.
Similar articles
-
Patent ductus arteriosus management in very-low-birth-weight prematurity: a place for an early operation?Eur J Cardiothorac Surg. 2024 May 3;65(5):ezae175. doi: 10.1093/ejcts/ezae175. Eur J Cardiothorac Surg. 2024. PMID: 38724226
-
Surgical Ligation Versus Percutaneous Closure of Patent Ductus Arteriosus in Very Low-Weight Preterm Infants: Which are the Real Benefits of the Percutaneous Approach?Pediatr Cardiol. 2018 Feb;39(2):398-410. doi: 10.1007/s00246-017-1768-5. Epub 2017 Nov 8. Pediatr Cardiol. 2018. PMID: 29119215
-
A conservative treatment of patent ductus arteriosus in very low birth weight infants.Early Hum Dev. 2017 Jan;104:45-49. doi: 10.1016/j.earlhumdev.2016.12.008. Epub 2016 Dec 30. Early Hum Dev. 2017. PMID: 28042972
-
Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus.Clin Perinatol. 2016 Mar;43(1):113-29. doi: 10.1016/j.clp.2015.11.008. Clin Perinatol. 2016. PMID: 26876125 Review.
-
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD003481. doi: 10.1002/14651858.CD003481.pub8. Cochrane Database Syst Rev. 2020. PMID: 32045960 Free PMC article.
Cited by
-
Improved Outcomes following a Conservative Approach to Hemodynamically Significant Patent Ductus Arteriosus: A Comparison across Two Periods.Cardiology. 2025;150(3):294-302. doi: 10.1159/000541477. Epub 2024 Sep 24. Cardiology. 2025. PMID: 39317174 Free PMC article.
-
Transcatheter closure of patent ductus arteriosus in preterm ventilation-dependent neonates: A case series report.Medicine (Baltimore). 2020 Nov 20;99(47):e22528. doi: 10.1097/MD.0000000000022528. Medicine (Baltimore). 2020. PMID: 33217791 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical